A randomized trial of tacrolimus vs Neoral cyclosporine in heart transplant recipients

被引：0
|
作者：
Kobashigawa, JA [1 ]
Moriguchi, JD [1 ]
Chuang, JM [1 ]
Wener, L [1 ]
Yeatman, L [1 ]
Ro, T [1 ]
Devereaux, D [1 ]
Kawata, N [1 ]
Laks, H [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2000年 / 35卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：222A / 222A
页数：1
相关论文
共 50 条
  • [1] Use of cyclosporine MEPC (Neoral) in heart transplant recipients
    Fukushima, N
    Ohtake, S
    Sawa, Y
    Nishimura, M
    Kobayashi, Y
    Shirakura, R
    Nakata, S
    Matsuda, H
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3337 - 3338
  • [2] Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: A comparison with cyclosporine neoral
    Wang, CH
    Ko, WJ
    Chou, N
    Wang, SS
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (08) : 2386 - 2387
  • [3] Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-neoral
    Nichelle, L
    Canet, S
    Garrigue, V
    Chong, G
    Mourad, G
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2824 - 2825
  • [4] Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients -: A large European trial
    Grimm, M
    Rinaldi, M
    Yonan, NA
    Arpesella, G
    Del Prado, JMA
    Pulpén, LA
    Villemot, JP
    Frigerio, M
    Lambert, JLR
    Crespo-Leiro, MG
    Almenar, L
    Duveau, D
    Ordonez-Fernandez, A
    Gandjbakhch, J
    Maccherini, M
    Laufer, G
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (06) : 1387 - 1397
  • [5] Conversion from neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis
    Busque, S
    Demers, P
    St-Louis, G
    Boily, JG
    Tousignant, J
    Lemieux, F
    Smeesters, C
    Corman, J
    Daloze, P
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1247 - 1248
  • [6] Pharmacokinetic, blood pressure, and renal effects of cyclosporine Sandimmune vs Neoral formulation in heart transplant recipients
    White, M
    Pelletier, GB
    Jesina, C
    Carrier, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 86178 - 86178
  • [7] A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients
    Mehra, MR
    Uber, PA
    Park, MH
    Prasad, AK
    Scott, RL
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1606 - 1607
  • [8] Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion
    White, M
    Haddad, H
    Leblanc, MH
    Giannetti, N
    Pflugfelder, P
    Davies, R
    Isaac, D
    Burton, J
    Chan, M
    Azevedo, E
    Howlett, J
    Ignaszewski, A
    Busque, S
    Cantarovich, M
    Ferguson, R
    Genest, J
    Ross, H
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (07): : 798 - 809
  • [9] CYCLOSPORINE NEORAL IN LIVER-TRANSPLANT RECIPIENTS
    LEVY, G
    ALTRAIF, I
    REZIEG, M
    ASFAR, S
    ROCHON, J
    FREEMAN, D
    WONG, PY
    BANKS, L
    ROACH, C
    ENGEL, K
    GRANT, D
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3184 - 3187
  • [10] Is a Switch to Cyclosporine from Tacrolimus a Risk in Heart Transplant Recipients?
    Chang, D.
    Kittleson, M.
    Patel, J.
    Kransdorf, E.
    Hamilton, M.
    Hage, A.
    Nikolova, A.
    Patel, N.
    Singer-Englar, T.
    Czer, L.
    Trento, A.
    Kobashigawa, J. A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S132 - S132
12345